These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9825395)
21. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial. Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217 [TBL] [Abstract][Full Text] [Related]
22. [Reiterated intravesical instillation of capsaicin in neurogenic detrusor hyperreflexia: a 5-years experience of 100 instillations]. de Sèze M; Wiart L; de Sèze MP; Joseph PA; Brochet B; Ferrière JM; Mazaux JM; Barat M Ann Readapt Med Phys; 2001 Nov; 44(8):514-24. PubMed ID: 11788114 [TBL] [Abstract][Full Text] [Related]
23. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury. George J; Tharion G; Richar J; Macaden AS; Thomas R; Bhattacharji S ScientificWorldJournal; 2007 Oct; 7():1683-90. PubMed ID: 17982563 [TBL] [Abstract][Full Text] [Related]
24. Intravesical capsaicin in neurologic impaired patients with detrusor hyperreflexia. Das A; Chancellor MB; Watanabe T; Sedor J; Rivas DA J Spinal Cord Med; 1996 Jul; 19(3):190-3. PubMed ID: 8819028 [TBL] [Abstract][Full Text] [Related]
25. Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats. Zhang X; Igawa Y; Ishizuka O; Nishizawa O; Andersson KE Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):473-9. PubMed ID: 12700886 [TBL] [Abstract][Full Text] [Related]
26. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. De Ridder D; Chandiramani V; Dasgupta P; Van Poppel H; Baert L; Fowler CJ J Urol; 1997 Dec; 158(6):2087-92. PubMed ID: 9366318 [TBL] [Abstract][Full Text] [Related]
28. The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. Wiart L; Joseph PA; Petit H; Dosque JP; de Sèze M; Brochet B; Deminière C; Ferrière JM; Mazaux JM; N'Guyen P; Barat M Spinal Cord; 1998 Feb; 36(2):95-9. PubMed ID: 9494998 [TBL] [Abstract][Full Text] [Related]
29. Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. Geirsson G; Fall M; Sullivan L J Urol; 1995 Nov; 154(5):1825-9. PubMed ID: 7563356 [TBL] [Abstract][Full Text] [Related]
30. Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. Cruz F; Guimarães M; Silva C; Rio ME; Coimbra A; Reis M J Urol; 1997 Feb; 157(2):585-9. PubMed ID: 8996364 [TBL] [Abstract][Full Text] [Related]
31. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127 [TBL] [Abstract][Full Text] [Related]
32. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. Chancellor MB; de Groat WC J Urol; 1999 Jul; 162(1):3-11. PubMed ID: 10379728 [TBL] [Abstract][Full Text] [Related]
33. Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder. Kim DY; Chancellor MB J Endourol; 2000 Feb; 14(1):97-103. PubMed ID: 10735579 [TBL] [Abstract][Full Text] [Related]
34. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. Brady CM; Apostolidis AN; Harper M; Yiangou Y; Beckett A; Jacques TS; Freeman A; Scaravilli F; Fowler CJ; Anand P BJU Int; 2004 Apr; 93(6):770-6. PubMed ID: 15049988 [TBL] [Abstract][Full Text] [Related]
35. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Apostolidis A; Brady CM; Yiangou Y; Davis J; Fowler CJ; Anand P Urology; 2005 Feb; 65(2):400-5. PubMed ID: 15708075 [TBL] [Abstract][Full Text] [Related]
36. Effects of intravesical instillation of ATP on rat bladder primary afferent activity and its relationship with capsaicin-sensitivity. Aizawa N; Igawa Y; Andersson KE; Iijima K; Nishizawa O; Wyndaele JJ Neurourol Urodyn; 2011 Jan; 30(1):163-8. PubMed ID: 20665548 [TBL] [Abstract][Full Text] [Related]
37. Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin. Avelino A; Cruz F Auton Neurosci; 2000 Dec; 86(1-2):37-46. PubMed ID: 11269923 [TBL] [Abstract][Full Text] [Related]
38. Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries. Kuo HC; Liu SH Neurourol Urodyn; 2011 Nov; 30(8):1541-5. PubMed ID: 21717505 [TBL] [Abstract][Full Text] [Related]
39. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. Lazzeri M; Beneforti P; Spinelli M; Zanollo A; Barbagli G; Turini D J Urol; 2000 Sep; 164(3 Pt 1):676-9. PubMed ID: 10953124 [TBL] [Abstract][Full Text] [Related]
40. Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis. Guo C; Yang B; Gu W; Peng B; Xia S; Yang F; Wen D; Geng J; Zhang Y; Zheng J PLoS One; 2013; 8(12):e82591. PubMed ID: 24376550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]